title: Low circulating T-helper cells in relapsing multiple myeloma.
abstract: Peripheral blood T-lymphocyte subsets were studied serially over a 6 year period in 50 patients with monoclonal gammopathy of unknown significance and multiple myeloma. The results were correlated with clinical status as measured by responsiveness to treatment (response vs. relapse). To allow assessment of the effects of treatment per se upon T-lymphocyte subset levels, patients were studied prior to as well as on and off therapy. After adjustment for treatment effects, the significant correlation (P less than 0.001) between low percentages of T4-bearing cells and relapse status persisted in all patients. Following multivariate analysis, beta 2-microglobulin and m-protein values correlated with relapse status, but these correlations were not unexpected since these parameters were often used in association with other clinical and laboratory findings to assess relapse status. The most striking finding of this study was the independent correlation between decreasing percent of T4 levels and increasing probability of relapse (P less than or equal to 0.003). Specifically, in this study the proportion of subjects with T4 levels less than 20% who relapsed was 67% regardless of other parameters. The strength of the correlation between the T4 values and relapse may provide insight into the biology of relapsing myeloma as well as adding a clinically useful test for disease assessment.
authors.affiliation: Department of Pathology, College of Medicine, University of Arizona, Tucson 85724.
authors.forename: M J
authors.initials: MJ
authors.lastname: Hicks
authors.forename: B G
authors.initials: BG
authors.lastname: Durie
authors.forename: D J
authors.initials: DJ
authors.lastname: Slymen
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D006801:Humans; D007958:Leukocyte Count; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood / Q000188:drug therapy / Q000276:immunology*; D009194:Myeloma Proteins / Q000097:blood; D012008:Recurrence; D013601:T-Lymphocytes / Q000145:classification / Q000276:immunology; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology*; D001613:beta 2-Microglobulin / Q000378:metabolism
chemical_list: D009194:Myeloma Proteins; D001613:beta 2-Microglobulin